BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 30063918)

  • 1. No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies.
    Engel C; Vasen HF; Seppälä T; Aretz S; Bigirwamungu-Bargeman M; de Boer SY; Bucksch K; Büttner R; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Järvinen H; Kloor M; von Knebel Doeberitz M; Koornstra JJ; van Kouwen M; Langers AM; van de Meeberg PC; Morak M; Möslein G; Nagengast FM; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Sanduleanu S; Schackert HK; Schmiegel W; Schulmann K; Steinke-Lange V; Strassburg CP; Vecht J; Verhulst ML; de Vos Tot Nederveen Cappel W; Zachariae S; Mecklin JP; Loeffler M;
    Gastroenterology; 2018 Nov; 155(5):1400-1409.e2. PubMed ID: 30063918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome.
    Sánchez A; Roos VH; Navarro M; Pineda M; Caballol B; Moreno L; Carballal S; Rodríguez-Alonso L; Ramon Y Cajal T; Llort G; Piñol V; López-Fernández A; Salces I; Picó MD; Rivas L; Bujanda L; Garzon M; Pizarro A; Martinez de Castro E; López-Arias MJ; Poves C; Garau C; Rodriguez-Alcalde D; Herraiz M; Alvarez-Urrutia C; Dacal A; Carrillo-Palau M; Cid L; Ponce M; Barreiro-Alonso E; Saperas E; Aguirre E; Romero C; Bastiaansen B; Gonzalez-Acosta M; Morales-Romero B; Ocaña T; Rivero-Sánchez L; Jung G; Bessa X; Cubiella J; Jover R; Rodríguez-Moranta F; Balmaña J; Brunet J; Castells A; Dekker E; Capella G; Serra-Burriel M; Moreira L; Pellise M; Balaguer F
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):611-621.e9. PubMed ID: 33157315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome.
    Mecklin JP; Aarnio M; Läärä E; Kairaluoma MV; Pylvänäinen K; Peltomäki P; Aaltonen LA; Järvinen HJ
    Gastroenterology; 2007 Oct; 133(4):1093-8. PubMed ID: 17919485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer.
    Engel C; Rahner N; Schulmann K; Holinski-Feder E; Goecke TO; Schackert HK; Kloor M; Steinke V; Vogelsang H; Möslein G; Görgens H; Dechant S; von Knebel Doeberitz M; Rüschoff J; Friedrichs N; Büttner R; Loeffler M; Propping P; Schmiegel W;
    Clin Gastroenterol Hepatol; 2010 Feb; 8(2):174-82. PubMed ID: 19835992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incident colorectal cancer in Lynch syndrome is usually not preceded by compromised quality of colonoscopy.
    Lappalainen J; Holmström D; Lepistö A; Saarnio J; Mecklin JP; Seppälä T
    Scand J Gastroenterol; 2019 Dec; 54(12):1473-1480. PubMed ID: 31829749
    [No Abstract]   [Full Text] [Related]  

  • 6. Colonoscopy screening compliance and outcomes in patients with Lynch syndrome.
    Newton K; Green K; Lalloo F; Evans DG; Hill J
    Colorectal Dis; 2015 Jan; 17(1):38-46. PubMed ID: 25213040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoma and colorectal cancer risks in Lynch syndrome, Lynch-like syndrome and familial colorectal cancer type X.
    Bucksch K; Zachariae S; Ahadova A; Aretz S; Büttner R; Görgens H; Holinski-Feder E; Hüneburg R; Kloor M; von Knebel Doeberitz M; Ladigan-Badura S; Moeslein G; Morak M; Nattermann J; Nguyen HP; Perne C; Redler S; Schmetz A; Steinke-Lange V; Surowy H; Vangala DB; Weitz J; Loeffler M; Engel C;
    Int J Cancer; 2022 Jan; 150(1):56-66. PubMed ID: 34469588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.
    Vasen HF; Abdirahman M; Brohet R; Langers AM; Kleibeuker JH; van Kouwen M; Koornstra JJ; Boot H; Cats A; Dekker E; Sanduleanu S; Poley JW; Hardwick JC; de Vos Tot Nederveen Cappel WH; van der Meulen-de Jong AE; Tan TG; Jacobs MA; Mohamed FL; de Boer SY; van de Meeberg PC; Verhulst ML; Salemans JM; van Bentem N; Westerveld BD; Vecht J; Nagengast FM
    Gastroenterology; 2010 Jun; 138(7):2300-6. PubMed ID: 20206180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yield of Lynch Syndrome Surveillance for Patients With Pathogenic Variants in DNA Mismatch Repair Genes.
    Goverde A; Eikenboom EL; Viskil EL; Bruno MJ; Doukas M; Dinjens WNM; Dubbink EJ; van den Ouweland AMW; Hofstra RMW; Wagner A; Spaander MCW
    Clin Gastroenterol Hepatol; 2020 May; 18(5):1112-1120.e1. PubMed ID: 31470178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer surveillance in Portuguese families with lynch syndrome: a cohort study.
    Vale Rodrigues R; Claro I; Lage P; Rosa I; Ferreira S; Pereira da Silva J; Dias Pereira A
    Int J Colorectal Dis; 2018 Jun; 33(6):695-702. PubMed ID: 29523990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations Between Mutations in MSH6 and PMS2 and Risk of Surveillance-detected Colorectal Cancer.
    Lamba M; Wakeman C; Ebel R; Hamilton S; Frampton C; Kiesanowski M; Griffiths B; Keating J; Parry S; Chalmers-Watson T
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2768-2774. PubMed ID: 32240831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adequacy evaluation of the annual colonoscopic surveillance and individual difference of disease phenotypes in Lynch syndrome.
    Taniguchi F; Tanakaya K; Sugano K; Akagi K; Ishida H; Nagahisa S; Nishimura S; Une Y; Kimura Y; Watanabe M; Utsumi M; Aoki H
    Jpn J Clin Oncol; 2020 Jun; 50(6):635-642. PubMed ID: 32372090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine Molecular Analysis for Lynch Syndrome Among Adenomas or Colorectal Cancer Within a National Screening Program.
    Goverde A; Wagner A; Bruno MJ; Hofstra RMW; Doukas M; van der Weiden MM; Dubbink HJ; Dinjens WNM; Spaander MCW
    Gastroenterology; 2018 Nov; 155(5):1410-1415. PubMed ID: 30063919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating colonoscopy screening intervals in patients with Lynch syndrome from a large Canadian registry.
    Aronson M; Gryfe R; Choi YH; Semotiuk K; Holter S; Ward T; Gallinger S; Cohen Z; Briollais L
    J Natl Cancer Inst; 2023 Jul; 115(7):778-787. PubMed ID: 36964717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report.
    Seppälä TT; Ahadova A; Dominguez-Valentin M; Macrae F; Evans DG; Therkildsen C; Sampson J; Scott R; Burn J; Möslein G; Bernstein I; Holinski-Feder E; Pylvänäinen K; Renkonen-Sinisalo L; Lepistö A; Lautrup CK; Lindblom A; Plazzer JP; Winship I; Tjandra D; Katz LH; Aretz S; Hüneburg R; Holzapfel S; Heinimann K; Valle AD; Neffa F; Gluck N; de Vos Tot Nederveen Cappel WH; Vasen H; Morak M; Steinke-Lange V; Engel C; Rahner N; Schmiegel W; Vangala D; Thomas H; Green K; Lalloo F; Crosbie EJ; Hill J; Capella G; Pineda M; Navarro M; Blanco I; Ten Broeke S; Nielsen M; Ljungmann K; Nakken S; Lindor N; Frayling I; Hovig E; Sunde L; Kloor M; Mecklin JP; Kalager M; Møller P
    Hered Cancer Clin Pract; 2019; 17():8. PubMed ID: 30858900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colonoscopy findings in high-risk individuals compared to an average-risk control population.
    Forsberg A; Kjellström L; Andreasson A; Jaramillo E; Rubio CA; Björck E; Agréus L; Talley NJ; Lindblom A
    Scand J Gastroenterol; 2015 Jul; 50(7):866-74. PubMed ID: 25762374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members.
    Järvinen HJ; Renkonen-Sinisalo L; Aktán-Collán K; Peltomäki P; Aaltonen LA; Mecklin JP
    J Clin Oncol; 2009 Oct; 27(28):4793-7. PubMed ID: 19720893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the appropriate screening protocol in Lynch syndrome?
    de Jong AE; Nagengast FM; Kleibeuker JH; van de Meeberg PC; van Wijk HJ; Cats A; Griffioen G; Vasen HF
    Fam Cancer; 2006; 5(4):373-8. PubMed ID: 16826316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metachronous colorectal cancer risk in Lynch syndrome patients-should the endoscopic surveillance be more intensive?
    Anyla M; Lefevre JH; Creavin B; Colas C; Svrcek M; Lascols O; Debove C; Chafai N; Tiret E; Parc Y
    Int J Colorectal Dis; 2018 Jun; 33(6):703-708. PubMed ID: 29532206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality colonoscopy and risk of interval cancer in Lynch syndrome.
    Haanstra JF; Vasen HF; Sanduleanu S; van der Wouden EJ; Koornstra JJ; Kleibeuker JH; de Vos Tot Nederveen Cappel WH
    Int J Colorectal Dis; 2013 Dec; 28(12):1643-9. PubMed ID: 23857598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.